Elevance Health, Inc. (ELV)
| Market Cap | 71.50B |
| Revenue (ttm) | 194.82B |
| Net Income (ttm) | 5.53B |
| Shares Out | 222.24M |
| EPS (ttm) | 24.39 |
| PE Ratio | 13.19 |
| Forward PE | 11.60 |
| Dividend | $6.84 (2.18%) |
| Ex-Dividend Date | Dec 5, 2025 |
| Volume | 1,173,485 |
| Open | 315.54 |
| Previous Close | 313.99 |
| Day's Range | 314.08 - 324.35 |
| 52-Week Range | 273.71 - 458.75 |
| Beta | 0.53 |
| Analysts | Buy |
| Price Target | 391.13 (+21.57%) |
| Earnings Date | Oct 21, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for ELV stock is "Buy." The 12-month stock price target is $391.13, which is an increase of 21.57% from the latest price.
News
Retirement: 2 Healthcare Giants To Buy At Discounted Prices
Merck offers strong dividend growth, a robust drug pipeline, and strategic acquisitions, positioning it well beyond Keytruda's patent expiration. MRK's 3.9% dividend yield, low payout ratio, and A+ cr...
First Eagle Rising Dividend Fund Q3 2025 Portfolio Review
Rising Dividend Fund A Shares (without sales charge*) posted a return of 9.70% in third quarter 2025. Leading contributors in the First Eagle Rising Dividend Fund this quarter included Alphabet Inc. C...
Columbia Contrarian Core Fund Q3 2025 Performance Review
The fund underperformed its benchmark, the Russell 1000 Index, during the third quarter. Videogame producer Electronic Art's was the top contributor during the period. Elevance Health was the top unde...
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
Elevance Health Foundation Invites Applications for $5 Million Patient Safety Prize Through New Community Action Leadership Initiative
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announced that applications will open December 9, 2025, for its inaugural $5 million Patient Safety Prize. With a focus on improving hea...
Health Insurer Stocks Wounded by Trump Comments, UNH Options Trade
Truth Social comments from President Trump against health care insurers sent stocks like Centene (CNC), HCA Healthcare (HCA), and Molina Healthcare (MOH) plunging Monday morning. Marley Kayden takes a...
First Eagle U.S. Fund Q3 2025 Portfolio Review
First Eagle U.S. Fund A Shares (without sales charge*) posted a return of 7.55% in third quarter 2025. Materials and industrials were the leading contributors among equity sectors, while consumer stap...
Columbia Balanced Fund Q3 2025 Portfolio Update
Electronic Arts' shares outperformed the broader market during the period, driven by renewed investor confidence and momentum surrounding several high-profile product announcements. eBay's shares surg...
Artisan Global Value Fund Q3 2025 Portfolio Update
Alphabet shares rose 38% during the quarter, which represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Elevan...
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery
Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation...
US health insurance premiums rose to $27,000 for families in 2025
Annual premiums for U.S. families with employer-sponsored health insurance in 2025 rose 6% to nearly $27,000, reflecting higher spending on popular weight-loss treatments and other prescription drugs,...
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
MINNEAPOLIS--(BUSINESS WIRE)-- #HistoSonics--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members.
Elevance: Checking Out The Q3 Report
Elevance Health reported Q3 results, beating consensus earnings estimates. However, the beat was due to one-off items. Key focus areas include Medical Cost Ratio stabilization, 2026 premium rate re-fi...
Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q3 2025 Earnings Call October 21, 2025 8:30 AM EDT Company Participants Nathan Rich - Vice President of Investor Relations Gail Boudreaux - President, CEO & Director ...
Elevance Health's Profits Eclipse $1.1 Billion Despite Rising Costs
Elevance Health Tuesday said third quarter net income rose to nearly $1.2 billion despite rising costs in its government subsidized health insurance plans.
Elevance Health Quarterly Profit Climbs as Memberships Slip
Elevance Health logged higher profit in the third quarter as revenue rose, despite a slip in overall memberships.
Elevance beats quarterly profit estimates as medical costs remained in check
Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check.
Elevance Health Reports Third Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across...
Managed Care Insurers Trading Down Ahead Of Earnings Season
US managed care insurers were trading down this week ahead of earnings season as the release of Medicare ratings and federal tax credit uncertainty appeared to weigh on stock prices. The S&P 500 and S...
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV)...
Many Large U.S. Insurers Trade In The Green As Shutdown Continues
Share of only a handful of large-cap US insurers finished the week in negative territory, while the majority of insurers were either flat or saw gains as Congress failed to reach an agreement to keep ...
Zhang: META at "Good Entry Point," ELV Turnaround Intact, Bearish on CZR
@OptionsPlay's Tony Zhang says he's been "bullish for quite some time" on Meta Platforms (META) due to how it uses A.I. to boost advertising revenue.
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review the...
Elevance Health: Undervalued Defensive Giant With Long-Term Upside
Elevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line c...
Northwest Middle School Unveils New Weight Room in Partnership with Elevance Health and Impact Fitness Foundation
INDIANAPOLIS--(BUSINESS WIRE)--Indianapolis Public Schools' Northwest Middle School today celebrated the unveiling of its newly transformed weight room, a project made possible through a partnership w...